The high serous CCN score could result from a shift in phenotype of the line concomitant with its loss of estrogen receptor (ER) as this is a distinguishing feature of type II endometrial cancer (serous histological subtype) [82]. The gene discussed is ESR1; the disease is endometrial cancer.